We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Bunge Global (BG) to Sell Its 50% Stake in BP Bunge Bioenergia
Read MoreHide Full Article
Bunge Global SA (BG - Free Report) announced that it signed a deal with its joint venture partner, BP plc (BP - Free Report) , to sell its 50% share in BP Bunge Bioenergia. As a result of this deal, the company will no longer have any interest in its bioenergy and sugarcane ethanol businesses in Brazil. This move is expected to help BG focus on its core businesses.
Bunge and BP created the joint venture, BP Bunge Bioenergia, in 2019 by merging the two companies' Brazilian bioenergy and sugarcane ethanol businesses. It operates 11 mills in the Southeast, North and Midwest areas of Brazil. Following the sale, BP will become the sole owner of BP Bunge Bioenergia.
The deal is expected to close by the end of the fourth quarter of 2024. The second and final monetization event of Bunge Global's shareholding in the business is estimated to generate net proceeds of $800 million, depending on the timing of closing and usual closing adjustments.
The transaction will allow the company to strengthen its balance sheet and focus and invest in its core businesses.
Bunge reported first-quarter 2024 adjusted earnings of $3.04 per share, which surpassed the Zacks Consensus Estimate of $2.55. The bottom line fell 7% year over year. Net sales were $13.4 billion in the quarter under review, down 12.5% from the year-ago quarter. The top line missed the Zacks Consensus Estimate of $13.78 billion.
Price Performance
Shares of Bunge Global have gained 17% over the past year compared with the industry's growth of 9.9%.
Image Source: Zacks Investment Research
Zacks Rank & Stocks to Consider
Bunge Global currently carries a Zacks Rank #3 (Hold).
The Zacks Consensus Estimate for Ero Copper’s 2024 earnings is pegged at $1.66 per share. The consensus estimate for 2024 earnings has moved 20.3% north in the past 60 days. It has an average trailing four-quarter earnings surprise of 53.9%. ERO shares have gained 9.5% in a year.
The Zacks Consensus Estimate for Ecolab’s 2024 earnings is pegged at $6.59 per share, indicating an increase of 26.5% from the prior year’s reported number. It has an average trailing four-quarter earnings surprise of 1.3%. ECL shares have gained 34.5% in a year.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Bunge Global (BG) to Sell Its 50% Stake in BP Bunge Bioenergia
Bunge Global SA (BG - Free Report) announced that it signed a deal with its joint venture partner, BP plc (BP - Free Report) , to sell its 50% share in BP Bunge Bioenergia. As a result of this deal, the company will no longer have any interest in its bioenergy and sugarcane ethanol businesses in Brazil. This move is expected to help BG focus on its core businesses.
Bunge and BP created the joint venture, BP Bunge Bioenergia, in 2019 by merging the two companies' Brazilian bioenergy and sugarcane ethanol businesses. It operates 11 mills in the Southeast, North and Midwest areas of Brazil. Following the sale, BP will become the sole owner of BP Bunge Bioenergia.
The deal is expected to close by the end of the fourth quarter of 2024. The second and final monetization event of Bunge Global's shareholding in the business is estimated to generate net proceeds of $800 million, depending on the timing of closing and usual closing adjustments.
The transaction will allow the company to strengthen its balance sheet and focus and invest in its core businesses.
Bunge reported first-quarter 2024 adjusted earnings of $3.04 per share, which surpassed the Zacks Consensus Estimate of $2.55. The bottom line fell 7% year over year. Net sales were $13.4 billion in the quarter under review, down 12.5% from the year-ago quarter. The top line missed the Zacks Consensus Estimate of $13.78 billion.
Price Performance
Shares of Bunge Global have gained 17% over the past year compared with the industry's growth of 9.9%.
Image Source: Zacks Investment Research
Zacks Rank & Stocks to Consider
Bunge Global currently carries a Zacks Rank #3 (Hold).
Two better-ranked stocks from the basic materials space are Ero Copper Corp. (ERO - Free Report) and Ecolab Inc. (ECL - Free Report) . ERO sports a Zacks Rank #1 (Strong Buy) at present and ECL carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for Ero Copper’s 2024 earnings is pegged at $1.66 per share. The consensus estimate for 2024 earnings has moved 20.3% north in the past 60 days. It has an average trailing four-quarter earnings surprise of 53.9%. ERO shares have gained 9.5% in a year.
The Zacks Consensus Estimate for Ecolab’s 2024 earnings is pegged at $6.59 per share, indicating an increase of 26.5% from the prior year’s reported number. It has an average trailing four-quarter earnings surprise of 1.3%. ECL shares have gained 34.5% in a year.